AlmataBio is a developer of a humanized monoclonal antibody intended to bind to interleukin-1β with high affinity and neutralize its activity. The company specializes in antibody that effectively prevents hidradenitis suppurativa and various inflammatory diseases in dermatology, gastroenterology, and rheumatology.